BP
PFE icon

BNP Paribas’s Pfizer PFE Stock Holding History

BNP Paribas’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5M Buy
810,791
+80,501
+11% +$2.11M 0.53% 33
2026
Q1 		$20.5M Buy
730,290
+94,316
+15% +$2.51M 0.65% 33
2025
Q4 		$15.8M Buy
635,974
+293,744
+86% +$7.41M 0.45% 43
2025
Q3 		$8.63M Buy
342,230
+23,327
+7% +$576K 0.26% 68
2025
Q2 		$7.73M Sell
318,903
-16,217
-5% -$378K 0.25% 74
2025
Q1 		$8.49M Buy
335,120
+47,541
+17% +$1.24M 0.35% 68
2024
Q4 		$8.42M Buy
287,579
+95,123
+49% +$2.58M 0.05% 60
2024
Q3 		$5.57M Buy
192,456
+4,203
+2% +$123K 0.23% 69
2024
Q2 		$5.27M Sell
188,253
-29,578
-14% -$814K 0.27% 67
2024
Q1 		$6.05M Buy
+217,831
New +$6.04M 0.28% 68

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BNP Paribas's PFE Position: Q2 2026 in Review

BNP Paribas increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $2.11M and bringing the position to 810,791 shares worth $19.5M. The position accounts for 0.53% of the portfolio, ranked #33.

BNP Paribas first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $20.5M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • BNP Paribas held 810,791 shares of Pfizer worth $19.5M as of Q2 2026.
  • BNP Paribas bought 80,501 Pfizer shares in Q2 2026, an estimated $2.11M.
  • Pfizer made up 0.53% of BNP Paribas's portfolio in Q2 2026, its #33 holding.
  • BNP Paribas first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • BNP Paribas's Pfizer position peaked at $20.5M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.